Ulipristal Sandoz
Ulipristal Sandoz is a medicine authorised by Swissmedic under authorisation number 68799. The authorisation holder is Sandoz Pharmaceuticals AG. The medicinal product code is Synthetic medicines and the dispensing category is B: Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly. First authorisation was granted on 30 March 2023 and the authorisation is limited until 29 March 2028. ATC code G03AD02 places the medicine in the group Sex hormones and modulators of the genital system.
| Authorisation number | 68799 |
|---|---|
| Name | Ulipristal Sandoz |
| Full name | Ulipristal Sandoz, Filmtablette |
| Authorisation holder | Sandoz Pharmaceuticals AG |
| Medicinal product code | Synthetic medicines |
| Dispensing category | B · Prescription only |
| ATC code | G03AD02 |
| First authorisation | 30 March 2023 |
| Authorisation validity | 29 March 2028 |
| No. | Name | Dispensing category | Authorisation date |
|---|---|---|---|
| 1 | Ulipristal Sandoz, Filmtablette | B | 30 March 2023 |
Scroll the table sideways
| Pack code | Quantity | Unit | ATC | IT code | Dispensing category |
|---|---|---|---|---|---|
| 1 | 1 | Tablette(n) | G03AD02 | 09.02.1. | B |
Scroll the table sideways
Medicines in the same ATC group
Other medicines from this authorisation holder
Frequently asked questions
Is Ulipristal Sandoz authorised in Switzerland?
Yes. Ulipristal Sandoz is authorised by Swissmedic under authorisation number 68799, data as of 01 September 2026. The authorisation is limited until 29 March 2028.
Which dispensing category does Ulipristal Sandoz have?
Ulipristal Sandoz is in dispensing category B. Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly.
Who is the authorisation holder of Ulipristal Sandoz?
The authorisation holder is Sandoz Pharmaceuticals AG. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.
Sources
Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.